Killing of microbes and cancer by the immune system with three mammalian pore-forming killer proteins

Frontiers in Immunology

Volumn 7, Issue NOV, 2016, Pages

  Podack, Eckhard R ^a   Munson, George P ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

C9; Complement; Cytotoxic T cells; MPEG1; Natural killer cells; Perforin 1; Perforin 2; Pore forming protein

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5B; COMPLEMENT COMPONENT C6; COMPLEMENT COMPONENT C7; COMPLEMENT COMPONENT C8; COMPLEMENT COMPONENT C9; DECAY ACCELERATING FACTOR; LYMPHOTOXIN; PERFORIN; TUMOR NECROSIS FACTOR;

CD8+ T LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; ELECTRON MICROSCOPY; IMMUNITY; MICROORGANISM; NATURAL KILLER CELL; NEOPLASM; NONHUMAN; REVIEW; ULTRACENTRIFUGATION;

EID: 85006147261     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2016.00464     Document Type: Review

References (66)

1. McCormack RM, Lyapichev K, Olsson ML, Podack ER, Munson GP. Enteric pathogens deploy cell cycle inhibiting factors to block the bactericidal activity of perforin-2. Elife (2015) 4:263. doi: 10.7554/eLife.06505
2. McCormack R, de Armas L, Shiratsuchi M, Podack ER. Killing machines: three pore-forming proteins of the immune system. Immunol Res (2013) 57:268-78. doi:10.1007/s12026-013-8469-9
3. McCormack R, Podack ER. Perforin-2/Mpeg1 and other pore-forming proteins throughout evolution. J Leukoc Biol (2015) 98:761-8. doi:10.1189/jlb.4MR1114-523RR
4. Podack ER, Tschopp J. Polymerization of the ninth component of complement (C9): formation of poly(C9) with a tubular ultrastructure resembling the membrane attack complex of complement. Proc Natl Acad Sci U S A (1982) 79:574-8. doi:10.1073/pnas.79.2.574
5. Podack ER, Preissner KT, Müller-Eberhard HJ. Inhibition of C9 polymerization within the SC5b-9 complex of complement by S-protein. Acta Pathol Microbiol Immunol Scand Suppl (1984) 284:89-96.
6. Podack ER, Müller-Eberhard HJ. Isolation of human S-protein, an inhibitor of the membrane attack complex of complement. J Biol Chem (1979) 254:9808-14.
7. Rosse WF, Parker CJ. Paroxysmal nocturnal haemoglobinuria. Clin Haematol (1985) 14:105-25.
8. Kinoshita T, Medof ME, Silber R, Nussenzweig V. Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria. J Exp Med (1985) 162:75-92. doi:10.1084/jem.162.1.75
9. Luzzatto L, Bessler M. The dual pathogenesis of paroxysmal nocturnal hemoglobinuria. Curr Opin Hematol (1996) 3:101-10. doi:10.1097/00062752-199603020-00001
10. Borsos T, Dourmashkin RR, Humphrey JH. Lesions in erythrocyte membranes caused by immune haemolysis. Nature (1964) 202:251-2. doi:10.1038/202251a0
11. Medhurst FA, Glynn AA, Dourmashkin RR. Lesions in Escherichia coli cell walls caused by the action of mouse complement. Immunology (1971) 20:441-50.
12. Podack ER, Dennert G. Assembly of two types of tubules with putative cytolytic function by cloned natural killer cells. Nature (1983) 302:442-5. doi:10.1038/302442a0
13. Law RHP, Lukoyanova N, Voskoboinik I, Caradoc-Davies TT, Baran K, Dunstone MA, et al. The structural basis for membrane binding and pore formation by lymphocyte perforin. Nature (2010) 468:447-51. doi:10.1038/nature09518
14. McCormack RM, de Armas LR, Shiratsuchi M, Fiorentino DG, Olsson ML, Lichtenheld MG, et al. Perforin-2 is essential for intracellular defense of parenchymal cells and phagocytes against pathogenic bacteria. Elife (2015) 4:28039. doi:10.7554/eLife.06508
15. Podack ER, Tschopp J. Circular polymerization of the ninth component of complement. Ring closure of the tubular complex confers resistance to detergent dissociation and to proteolytic degradation. J Biol Chem (1982) 257:15204-12.
16. Tranum-Jensen J, Bhakdi S, Bhakdi-Lehnen B, Bjerrum OJ, Speth V. Complement lysis: the ultrastructure and orientation of the C5b-9 complex on target sheep erythrocyte membranes. Scand J Immunol (1978) 7:45-6. doi:10.1111/j.1365-3083.1978.tb00425.x
17. Tschopp J, Podack ER. Membranolysis by the ninth component of human complement. Biochem Biophys Res Commun (1981) 100:1409-14. doi:10.1016/0006-291X(81)91981-1
18. Tschopp J, Podack ER, Müller-Eberhard HJ. Ultrastructure of the membrane attack complex of complement: detection of the tetramolecular C9-polymerizing complex C5b-8. Proc Natl Acad Sci U S A (1982) 79:7474-8. doi:10.1073/pnas.79.23.7474
19. Schreiber RD, Morrison DC, Podack ER, Müller-Eberhard HJ. Bactericidal activity of the alternative complement pathway generated from 11 isolated plasma proteins. J Exp Med (1979) 149:870-82. doi:10.1084/jem.149.4.870
20. Preissner KP, Podack ER, Müller-Eberhard HJ. SC5b-7, SC5b-8 and SC5b-9 complexes of complement: ultrastructure and localization of the S-protein (vitronectin) within the macromolecules. Eur J Immunol (1989) 19:69-75. doi:10.1002/eji.1830190112
21. Mayer MM. Mechanism of cytolysis by complement. Proc Natl Acad Sci U S A (1972) 69:2954-8. doi:10.1073/pnas.69.10.2954
22. Tschopp J, Podack ER, Müller-Eberhard HJ. The membrane attack complex of complement: C5b-8 complex as accelerator of C9 polymerization. J Immunol (1985) 134:495-9.
23. Slade DJ, Lovelace LL, Chruszcz M, Minor W, Lebioda L, Sodetz JM. Crystal structure of the MACPF domain of human complement protein C8 alpha in complex with the C8 gamma subunit. J Mol Biol (2008) 379:331-42. doi:10.1016/j.jmb.2008.03.061
24. Lukoyanova N, Kondos SC, Farabella I, Law RHP, Reboul CF, Caradoc-Davies TT, et al. Conformational changes during pore formation by the perforin-related protein pleurotolysin. PLoS Biol (2015) 13:e1002049. doi:10.1371/journal.pbio.1002049
25. Hadders MA, Bubeck D, Roversi P, Hakobyan S, Forneris F, Morgan BP, et al. Assembly and regulation of the membrane attack complex based on structures of C5b6 and sC5b9. Cell Rep (2012) 1:200-7. doi:10.1016/j.celrep.2012.02.003
26. Rosado CJ, Kondos S, Bull TE, Kuiper MJ, Law RHP, Buckle AM, et al. The MACPF/CDC family of pore-forming toxins. Cell Microbiol (2008) 10:1765-74. doi:10.1111/j.1462-5822.2008.01191.x
27. Hadders MA, Beringer DX, Gros P. Structure of C8alpha-MACPF reveals mechanism of membrane attack in complement immune defense. Science (2007) 317:1552-4. doi:10.1126/science.1147103
28. Rosado CJ, Buckle AM, Law RHP, Butcher RE, Kan W-T, Bird CH, et al. A common fold mediates vertebrate defense and bacterial attack. Science (2007) 317:1548-51. doi:10.1126/science.1144706
29. Dudkina NV, Spicer BA, Reboul CF, Conroy PJ, Lukoyanova N, Elmlund H, et al. Structure of the poly-C9 component of the complement membrane attack complex. Nat Commun (2016) 7:10588. doi:10.1038/ncomms10588
30. Rose AS, Hildebrand PW. NGL Viewer: a web application for molecular visualization. Nucleic Acids Res (2015) 43:W576-9. doi:10.1093/nar/gkv402
31. Gascoigne NR, Chien Y, Becker DM, Kavaler J, Davis MM. Genomic organization and sequence of T-cell receptor beta-chain constant-and joining-region genes. Nature (1984) 310:387-91. doi:10.1038/310387a0
32. Kolb WP, Granger GA. Lymphocyte in vitro cytotoxicity: characterization of human lymphotoxin. Proc Natl Acad Sci U S A (1968) 61:1250-5. doi:10.1073/pnas.61.4.1250
33. Oettgen HF, Carswell EA, Kassel RL, Fiore N, Williamson B, Hoffmann MK, et al. Endotoxin-induced tumor necrosis factor. Recent Results Cancer Res (1980) 75:207-12. doi:10.1007/978-3-642-81491-4_32
34. Bonavida B, Wright SC. Soluble cytotoxic factors and the mechanism of NK cell mediated cytotoxicity. Adv Exp Med Biol (1982) 146:379-88. doi:10.1007/978-1-4684-8959-0_22
35. Filippini A, Taffs RE, Sitkovsky MV. Extracellular ATP in T-lymphocyte activation: possible role in effector functions. Proc Natl Acad Sci U S A (1990) 87:8267-71. doi:10.1073/pnas.87.21.8267
36. Berke G, Hu V, McVey E, Clark W. A common role for target cell histocompatibility antigens in both nonspecific and specific T lymphocyte-mediated cytolysis. J Cell Biochem (1982) 18:337-49. doi:10.1002/jcb.1982.240180307
37. Berke G, Hu V, McVey E, Clark WR. T lymphocyte-mediated cytolysis. I. A common mechanism for target recognition in specific and lectin-dependent cytolysis. J Immunol (1981) 127:776-81.
38. Dourmashkin RR, Deteix P, Simone CB, Henkart P. Electron microscopic demonstration of lesions in target cell membranes associated with antibody-dependent cellular cytotoxicity. Clin Exp Immunol (1980) 42:554-60.
39. Dennert G, Podack ER. Cytolysis by H-2-specific T killer cells. Assembly of tubular complexes on target membranes. J Exp Med (1983) 157:1483-95. doi:10.1084/jem.157.5.1483
40. Clark W, Ostergaard H, Gorman K, Torbett B. Molecular mechanisms of CTL-mediated lysis: a cellular perspective. Immunol Rev (1988) 103:37-51. doi:10.1111/j.1600-065X.1988.tb00748.x
41. Blumenthal R, Millard PJ, Henkart MP, Reynolds CW, Henkart PA. Liposomes as targets for granule cytolysin from cytotoxic large granular lymphocyte tumors. Proc Natl Acad Sci U S A (1984) 81:5551-5. doi:10.1073/pnas.81.17.5551
42. Henkart PA, Millard PJ, Reynolds CW, Henkart MP. Cytolytic activity of purified cytoplasmic granules from cytotoxic rat large granular lymphocyte tumors. J Exp Med (1984) 160:75-93. doi:10.1084/jem.160.1.75
43. Gillis S, Smith KA. Long term culture of tumour-specific cytotoxic T cells. Nature (1977) 268:154-6. doi:10.1038/268154a0
44. Podack ER, Konigsberg PJ. Cytolytic T cell granules. Isolation, structural, biochemical, and functional characterization. J Exp Med (1984) 160:695-710. doi:10.1084/jem.160.3.695
45. Lichtenheld MG, Olsen KJ, Lu P, Lowrey DM, Hameed A, Hengartner H, et al. Structure and function of human perforin. Nature (1988) 335:448-51. doi:10.1038/335448a0
46. Lowrey DM, Aebischer T, Olsen K, Lichtenheld M, Rupp F, Hengartner H, et al. Cloning, analysis, and expression of murine perforin 1 cDNA, a component of cytolytic T-cell granules with homology to complement component C9. Proc Natl Acad Sci U S A (1989) 86:247-51. doi:10.1073/pnas.86.1.247
47. Shinkai Y, Takio K, Okumura K. Homology of perforin to the ninth component of complement (C9). Nature (1988) 334:525-7. doi:10.1038/334525a0
48. DiScipio RG, Gehring MR, Podack ER, Kan CC, Hugli TE, Fey GH. Nucleotide sequence of cDNA and derived amino acid sequence of human complement component C9. Proc Natl Acad Sci U S A (1984) 81:7298-302. doi:10.1073/pnas.81.23.7298
49. Capecchi MR. Altering the genome by homologous recombination. Science (1989) 244:1288-92.
50. Kägi D, Ledermann B, Bürki K, Seiler P, Odermatt B, Olsen KJ, et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature (1994) 369:31-7. doi:10.1038/369031a0
51. van den Broek MF, Kägi D, Zinkernagel RM, Hengartner H. Perforin dependence of natural killer cell-mediated tumor control in vivo. Eur J Immunol (1995) 25:3514-6. doi:10.1002/eji.1830251246
52. Podack ER. Perforin, killer cells and gene transfer immunotherapy for cancer. Curr Top Microbiol Immunol (1995) 198:121-30.
53. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, Mathew PA, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science (1999) 286:1957-9. doi:10.1126/science.286.5446.1957
54. Spilsbury K, O'Mara MA, Wu WM, Rowe PB, Symonds G, Takayama Y. Isolation of a novel macrophage-specific gene by differential cDNA analysis. Blood (1995) 85:1620-9.
55. Fields KA, McCormack R, de Armas LR, Podack ER. Perforin-2 restricts growth of Chlamydia trachomatis in macrophages. Infect Immun (2013) 81:3045-54. doi:10.1128/IAI.00497-13
56. McCormack R, de Armas LR, Shiratsuchi M, Ramos JE, Podack ER. Inhibition of intracellular bacterial replication in fibroblasts is dependent on the perforin-like protein (perforin-2) encoded by macrophage-expressed gene 1. J Innate Immun (2013) 5:185-94. doi:10.1159/000345249
57. McCormack R, Bahnan W, Shrestha N, Boucher J, Barreto M, Barrera CM, et al. Perforin-2 protects host cells and mice by restricting the vacuole to cytosol transitioning of a bacterial pathogen. Infect Immun (2016) 84:1083-91. doi:10.1128/IAI.01434-15
58. Benard EL, Racz PI, Rougeot J, Nezhinsky AE, Verbeek FJ, Spaink HP, et al. Macrophage-expressed perforins Mpeg1 and Mpeg1.2 have an anti-bacterial function in zebrafish. J Innate Immun (2014) 7(2):136-52. doi:10.1159/000366103
59. D'Angelo ME, Dunstone MA, Whisstock JC, Trapani JA, Bird PI. Perforin evolved from a gene duplication of MPEG1, followed by a complex pattern of gene gain and loss within Euteleostomi. BMC Evol Biol (2012) 12:59. doi:10.1186/1471-2148-12-59
60. Hsu Y, Jubelin G, Taieb F, Nougayrède J-P, Oswald E, Stebbins CE. Structure of the cyclomodulin Cif from pathogenic Escherichia coli. J Mol Biol (2008) 384:465-77. doi:10.1016/j.jmb.2008.09.051
61. Jubelin G, Taieb F, Duda DM, Hsu Y, Samba-Louaka A, Nobe R, et al. Pathogenic bacteria target NEDD8-conjugated cullins to hijack host-cell signaling pathways. PLoS Pathog (2010) 6:e1001128. doi:10.1371/journal.ppat.1001128
62. Crow A, Race PR, Jubelin G, Varela Chavez C, Escoubas J-M, Oswald E, et al. Crystal structures of Cif from bacterial pathogens Photorhabdus luminescens and Burkholderia pseudomallei. PLoS One (2009) 4:e5582. doi:10.1371/journal.pone.0005582
63. Petroski MD, Deshaies RJ. Function and regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol (2005) 6:9-20. doi:10.1038/nrm1547
64. Calabrese MF, Scott DC, Duda DM, Grace CRR, Kurinov I, Kriwacki RW, et al. A RING E3-substrate complex poised for ubiquitin-like protein transfer: structural insights into cullin-RING ligases. Nat Struct Mol Biol (2011) 18:947-9. doi:10.1038/nsmb.2086
65. Lewis LA, Ram S. Meningococcal disease and the complement system. Virulence (2014) 5:98-126. doi:10.4161/viru.26515
66. Bradley DT, Bourke TW, Fairley DJ, Borrow R, Shields MD, Zipfel PF, et al. Susceptibility to invasive meningococcal disease: polymorphism of complement system genes and Neisseria meningitidis factor H binding protein. PLoS One (2015) 10:e0120757. doi:10.1371/journal.pone.0120757